Search

Your search keyword '"Lung surfactant"' showing total 692 results

Search Constraints

Start Over You searched for: Descriptor "Lung surfactant" Remove constraint Descriptor: "Lung surfactant"
692 results on '"Lung surfactant"'

Search Results

151. Influence of Carbon Nanosheets on the Behavior of 1,2-Dipalmitoyl-sn-glycerol-3-phosphocholine Langmuir Monolayers

152. Per- and polyfluoroalkyl substances (PFASs) modify lung surfactant function and pro-inflammatory responses in human bronchial epithelial cells

153. Efecto antibacteriano de Surfacen® y la proteína A del surfactante pulmonar frente a un aislado clínico de Streptococcus pneumoniae.

154. Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized 83Kr.

155. Dipalmitoyl-Phosphatidylcholine Biosynthesis is Induced by Non-Injurious Mechanical Stretch in a Model of Alveolar Type II Cells.

156. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.

157. Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.

158. The Surfactant System Protects Both Fetus and Newborn.

159. Mixed DPPC–cholesterol Langmuir monolayers in presence of hydrophilic silica nanoparticles

160. Surface pressure induced structural transitions of an amphiphilic peptide in pulmonary surfactant systems by an in situ PM-IRRAS study

161. A54145 Factor D Is Not Less Susceptible to Inhibition by Lung Surfactant than Daptomycin.

162. Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles.

163. Properties of mixed monolayers of clinical lung surfactant, serum albumin and hydrophilic polymers

164. Lipid monolayer collapse and microbubble stability

165. DPPC–DOPC Langmuir monolayers modified by hydrophilic silica nanoparticles: Phase behaviour, structure and rheology

166. Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement

167. Characterization of VAMP-2 in the lung: implication in lung surfactant secretion.

168. Effects of the lung surfactant protein B construct Mini-B on lipid bilayer order and topography.

169. Premature birth and diseases in premature infants: common genetic background??

170. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles

171. Analysis of Bronchoalveolar Lavage Fluid Adhering to Lung Surfactant.

172. Analysis of lung surfactant phosphatidylcholine metabolism in transgenic mice using stable isotopes

173. Biophysical investigation of the interfacial properties of cationic fluorocarbon/hydrocarbon hybrid surfactant: Mimicking the lung surfactant protein C

174. Lessons from the biophysics of interfaces: Lung surfactant and tear fluid

175. Phospholipid packing and hydration in pulmonary surfactant membranes and films as sensed by LAURDAN

176. Lamellar body counts on gastric aspirates for prediction of respiratory distress syndrome.

177. Physicochemical studies on the interaction of serum albumin with pulmonary surfactant extract in films and bulk bilayer phase

178. Impaired phospholipases A2 production by stimulated macrophages from patients with acute respiratory distress syndrome

179. Mimicking SP-C palmitoylation on a peptoid-based SP-B analogue markedly improves surface activity

180. Specific interaction restrains structural transitions of an amphiphilic peptide in pulmonary surfactant model systems: An in situ PM-IRRAS investigation

181. 1-Cysteine peroxiredoxin: A dual-function enzyme with peroxidase and acidic Ca2+-independent phospholipase A2 activities

182. Surface view of the lateral organization of lipids and proteins in lung surfactant model systems—A ToF-SIMS approach

184. Partitioning, dynamics, and orientation of lung surfactant peptide KL4 in phospholipid bilayers

185. P63 (CKAP4) as an SP-A Receptor: Implications for Surfactant Turnover.

186. Phospholipase A2 subclasses in acute respiratory distress syndrome

187. Human neutrophil elastase and lung surfactant in acute respiratory distress syndrome.

188. Elastasa de neutrófilos humana y surfactante pulmonar en el síndrome de distrés respiratorio agudo.

189. The effect of acids on dipalmitoyl phosphatidylcholine (DPPC) monolayers and liposomes

190. Potential health risks of the interaction of microplastics and lung surfactant.

191. Dispersion medium modulates oxidative stress response of human lung epithelial cells upon exposure to carbon nanomaterial samples

192. Molecular modeling of nanoplastic transformations in alveolar fluid and impacts on the lung surfactant film.

193. SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro

194. Effect of mycolic acid on surface activity of binary surfactant lipid monolayers

195. Effect of buffer composition and preparation protocol on the dispersion stability and interfacial behavior of aqueous DPPC dispersions

196. Interactions of the C-terminus of lung surfactant protein B with lipid bilayers are modulated by acyl chain saturation

197. Influence of dipalmitoylphosphatidylcholine on the dissolution of Brazilian chrysotile

198. The molecular mechanism of lipid monolayer collapse.

199. Thin liquid films as a model to study surfactant layers on the alveolar surface

200. Collapse Mechanisms of Langmuir Monolayers.

Catalog

Books, media, physical & digital resources